Infliximab Use in a Child With Ulcerative Colitis and Prior In Utero Exposure to Infliximab

Gastroenterology. 2020 May;158(6):1834-1835. doi: 10.1053/j.gastro.2020.01.002. Epub 2020 Jan 8.

Authors

Jessica Lim¹, Muhammad B Hammami², Uma Mahadevan³

Affiliations

¹ Department of Medicine, Division of Gastroenterology, University of California, San Francisco, San Francisco, California.
² Department of Medicine, University of California, Riverside, Riverside, California; Division of Gastroenterology and Hepatology, Veterans Affairs Loma Linda Health Care System, Loma Linda, California.
³ Department of Medicine, Division of Gastroenterology, University of California, San Francisco, San Francisco, California. Electronic address: Uma.mahadevan@ucsf.edu.

PMID: 31926172
DOI: 10.1053/j.gastro.2020.01.002

No abstract available

Publication types

Case Reports

MeSH terms

Adolescent
Adult
Child
Child, Preschool
Colitis, Ulcerative / blood
Colitis, Ulcerative / diagnosis
Colitis, Ulcerative / drug therapy*
Colitis, Ulcerative / immunology
Colonoscopy
Crohn Disease / drug therapy*
Crohn Disease / immunology
Drug Therapy, Combination
Female
Gastrointestinal Agents / immunology
Gastrointestinal Agents / pharmacokinetics
Gastrointestinal Agents / therapeutic use*
Humans
Infliximab / immunology
Infliximab / pharmacokinetics
Infliximab / therapeutic use*
Male
Maternal Exposure*
Medical History Taking
Pregnancy
Pregnancy Complications / drug therapy*
Pregnancy Complications / immunology
Remission Induction / methods
Retrospective Studies
Treatment Outcome

Substances

Gastrointestinal Agents
Infliximab